Pieringer, Herwig <br/><br/>
Augmentation index in patients with rheumatoid arthritis and ankylosing spondylitis treated with infliximab.  [electronic resource] 

 -  Clinical rheumatology  Jul 2010 
 - 723-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1434-9949 
<br/><br/><label>Standard No.: </label>10.1007/s10067-010-1388-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--pharmacology<br/>Antirheumatic Agents--pharmacology<br/>Arthritis, Rheumatoid--drug therapy<br/>Biomarkers--blood<br/>Cardiovascular Diseases--drug therapy<br/>Female<br/>Humans<br/>Inflammation--drug therapy<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Reference Standards<br/>Risk Factors<br/>Spondylitis, Ankylosing--drug therapy<br/>Treatment Outcome<br/>Vascular Resistance--drug effects